Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Breast Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Hepatocellular; Drug-Related Side Effects and Adverse Reactions | Phase 2 | ClinicalTrials |
| Carcinoma, Squamous Cell; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck | Phase 2 | ClinicalTrials |
| Head and Neck Neoplasms | Phase 3 | ClinicalTrials |
| Carcinoma; Carcinoma, Squamous Cell | Phase 2 | ClinicalTrials |
| Colonic Neoplasms; Microsatellite Instability | Phase 4 | ClinicalTrials |
| Colonic Neoplasms | Phase 3 | ClinicalTrials |
| Colorectal Neoplasms | Phase 2 | ClinicalTrials |
| Colorectal Neoplasms | Phase 1 | ClinicalTrials |
CONTENTS